Radiolabeling is a specific scientific technique used to generate data for various applications. Within the pharmaceutical industry, radiolabeled APIs are an essential part of the drug research and development process. Isotopic radiolabeling is a challenging and multifaceted procedure due to the complexity of API synthesis. Chemists must select a metabolically stable labeling position and utilize a chosen radioisotope to formulate effective reactions and results.
Of the numerous radiolabeled compound options available, carbon-14 is the chief radioactive isotope researchers select to catalyze facts and statistics. Why is carbon-14 the element of choice for radiolabeling? Let’s examine closer the reasons for choosing this particular radiolabel over another.
A Long Half-Life: Ideal for Any Length of Study
Carbon is an element with three natural isotopes. As the radioisotope of carbon, C-14 has a radioactive period of approximately 5700 years—this duration is perfect for use in modern research and applications. Statistically, its longer half-life is why the main application of carbon-14 is radiometric carbon dating. However, in the medical sector, these characteristics apply directly to research and development studies. Regardless of the timeframe of a specific study, there is no need for corrections. The radioisotope will not decay during use.
Critical Detection Technology: Quantitative and Qualitative Data
Obtaining reliable quantitative and qualitative data is the core focus of pharmaceutical research and development. The ability to produce these kinds of results consistently is why carbon-14 is the element of choice for radiolabeling. Experts are aware that C-14 radiolabeled material is a prerequisite for certain clinical studies to receive the best possible analysis data. Carbon-14 facilitates the sensitive detection of an active substance and its reaction and breakdown products.
Superiorly Prepares Compounds Using Custom Synthesis
Work involving radiolabeled compounds presents a wider array of challenges beyond traditional chemical synthesis. As a radioactive beta decay emitter, C-14 emits non-ionizing radiation, allocating safer handling capabilities than gamming emitting isotopes. As a stable label, chemists can incorporate C-14 into the carbon framework of an API without the need to alter the chemical structure. Ergo, carbon-14 remains superior for preparing radiolabeled compounds and performing more customized synthesis.
Turn to Moravek for custom synthesis services or GMP C-14 radiolabeling. Our highly skilled team of chemists has extensive experience in a wide range of techniques and procedures. We have the ability to accomplish your custom goals and achieve the data objectives of your study. Contact us to learn more about our facilities, systems, and solutions.